Nephros, Inc. (NEPH)

USD 1.48

(-3.9%)

Operating Expenses Summary of Nephros, Inc.

  • Nephros, Inc.'s latest annual operating expenses in 2023 was 9.78 Million USD , up 7.92% from previous year.
  • Nephros, Inc.'s latest quarterly operating expenses in 2024 Q1 was 2.35 Million USD , down -10.12% from previous quarter.
  • Nephros, Inc. reported a annual operating expenses of 9.06 Million USD in annual operating expenses 2022, down -10.04% from previous year.
  • Nephros, Inc. reported a annual operating expenses of 10.07 Million USD in annual operating expenses 2021, up 7.02% from previous year.
  • Nephros, Inc. reported a quarterly operating expenses of 2.19 Million USD for 2024 Q2, down -6.75% from previous quarter.
  • Nephros, Inc. reported a quarterly operating expenses of 2.41 Million USD for 2023 Q1, up 9.76% from previous quarter.

Annual Operating Expenses Chart of Nephros, Inc. (2023 - 2001)

Historical Annual Operating Expenses of Nephros, Inc. (2023 - 2001)

Year Operating Expenses Operating Expenses Growth
2023 9.78 Million USD 7.92%
2022 9.06 Million USD -10.04%
2021 10.07 Million USD 7.02%
2020 9.41 Million USD 0.23%
2019 9.39 Million USD 51.07%
2018 6.21 Million USD 37.65%
2017 4.51 Million USD 8.53%
2016 4.16 Million USD -7.1%
2015 4.48 Million USD 15.85%
2014 3.86 Million USD -7.0%
2013 4.15 Million USD -5.54%
2012 4.4 Million USD 38.55%
2011 3.17 Million USD 5.55%
2010 3.01 Million USD -9.39%
2009 3.32 Million USD -53.37%
2008 7.12 Million USD -8.63%
2007 7.79 Million USD -1.05%
2006 7.88 Million USD -5.83%
2005 8.36 Million USD 10.55%
2004 7.57 Million USD 51.59%
2003 4.99 Million USD 143.04%
2002 2.05 Million USD 178.51%
2001 737.85 Thousand USD 0.0%

Peer Operating Expenses Comparison of Nephros, Inc.

Name Operating Expenses Operating Expenses Difference
Akoya Biosciences, Inc. 104.27 Million USD 90.617%
AngioDynamics, Inc. 252.41 Million USD 96.124%
AtriCure, Inc. 327.05 Million USD 97.008%
Avinger, Inc. 18.63 Million USD 47.505%
Azenta, Inc. 336.26 Million USD 97.09%
BioLife Solutions, Inc. 117.57 Million USD 91.679%
The Cooper Companies, Inc. 1.82 Billion USD 99.464%
Daxor Corporation 1.28 Million USD -664.068%
Ekso Bionics Holdings, Inc. 24.19 Million USD 59.555%
Femasys Inc. 15.2 Million USD 35.633%
GlucoTrack, Inc. 7.1 Million USD -37.725%
Harvard Bioscience, Inc. 58.58 Million USD 83.298%
Hologic, Inc. 1.34 Billion USD 99.273%
ICU Medical, Inc. 717.04 Million USD 98.636%
Intuitive Surgical, Inc. 2.96 Billion USD 99.67%
KORU Medical Systems, Inc. 26.1 Million USD 62.525%
LeMaitre Vascular, Inc. 90.33 Million USD 89.169%
Innovative Eyewear, Inc. -119.32 Thousand USD 8299.18%
Innovative Eyewear, Inc. -119.32 Thousand USD 8299.18%
Masimo Corporation 867 Million USD 98.872%
Microbot Medical Inc. 9.85 Million USD 0.72%
Meihua International Medical Technologies Co., Ltd. 18.42 Million USD 46.884%
Merit Medical Systems, Inc. 459.92 Million USD 97.873%
NovoCure Limited 613.92 Million USD 98.406%
NEXGEL, Inc. 4.09 Million USD -138.867%
NEXGEL, Inc. 4.09 Million USD -138.867%
Singular Genomics Systems, Inc. 102.24 Million USD 90.431%
OraSure Technologies, Inc. 125.34 Million USD 92.194%
Pro-Dex, Inc. 7.37 Million USD -32.61%
Pulse Biosciences, Inc. 43.57 Million USD 77.546%
Predictive Oncology Inc. 15.22 Million USD 35.756%
Precision Optics Corporation, Inc. 8.52 Million USD -14.807%
QuidelOrtho Corporation 1.35 Billion USD 99.278%
Repligen Corporation 261.12 Million USD 96.253%
Sanara MedTech Inc. 61.12 Million USD 83.994%
STAAR Surgical Company 224.55 Million USD 95.643%
Sharps Technology, Inc. 10.12 Million USD 3.384%
Utah Medical Products, Inc. 13.26 Million USD 26.22%
DENTSPLY SIRONA Inc. 1.79 Billion USD 99.455%
Jin Medical International Ltd. 3.91 Million USD -149.747%